Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:1093-1100, doi:10.1016/j.jacc.2005.11.046 (Published online 21 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (112)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grundy, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grundy, S. M.

Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds

Scott M. Grundy, MD, PhD*,*

Center for Human Nutrition and Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas


Figure 1
View larger version (22K):

[in a new window]
 
Figure 1 Progression and outcomes of the metabolic syndrome. The metabolic syndrome arises largely out of abdominal obesity. With aging and increasing obesity, metabolic risk factors worsen. Many persons with the metabolic syndrome eventually develop type 2 diabetes. As the syndrome advances, risk for cardiovascular disease and its complications increase. Once diabetes develops, diabetic complications other than cardiovascular disease often develop. The metabolic syndrome encompasses each stage in the development of risk factors and type 2 diabetes.

 

Figure 2
View larger version (26K):

[in a new window]
 
Figure 2 Interrelations and overlap of metabolic syndrome with insulin resistance, prediabetes, and type 2 diabetes. According to the insulin resistance hypothesis, the metabolic syndrome is caused predominantly by insulin resistance. The latter also contributes to prediabetes and, ultimately, to type 2 diabetes. About 75% of people with prediabetes and 86% of people with type 2 diabetes have the metabolic syndrome. Both metabolic syndrome and type 2 diabetes are known to predict cardiovascular disease.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement